A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN
Condition: Respiratory Tract Infection · Sponsor: Pfizer
About this study
This Phase 2b study will evaluate the safety, tolerability, and immunogenicity of an RSV vaccine in pregnant participants who receive either one of 2 dose levels of the vaccine, formulated with or without aluminum hydroxide, or placebo, and investigate safety and characteristics of antibodies in their infants.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (159)
| Children's of Alabama | Birmingham, Alabama, United States | — |
| UAB Women & Infants Center - UAB Medicine | Birmingham, Alabama, United States | — |
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| Cullman Clinical Research, Inc | Cullman, Alabama, United States | — |
| Cullman Primary Care, PC | Cullman, Alabama, United States | — |
| Cullman Regional | Cullman, Alabama, United States | — |
| Arrowhead Hospital | Glendale, Arizona, United States | — |
| Abrazo West Campus Hospital | Goodyear, Arizona, United States | — |
| St. Joseph Hospital | Phoenix, Arizona, United States | — |
| MedPharmics, LLC | Phoenix, Arizona, United States | — |
| Mesquite Pediatrics | Tucson, Arizona, United States | — |
| Watching Over Mothers and Babies | Tucson, Arizona, United States | — |
+ 147 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04032093